Filing Details
- Accession Number:
- 0001209191-15-061938
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-21 19:04:16
- Reporting Period:
- 2015-07-21
- Filing Date:
- 2015-07-21
- Accepted Time:
- 2015-07-21 19:04:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1290149 | Pronai Therapeutics Inc | DNAI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1341382 | N James Topper | C/O Frazier Healthcare 601 Union St., Two Union Sq., Ste. 3200 Seattle WA 98101 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-07-21 | 1,869,606 | $0.00 | 1,869,606 | No | 4 | C | Indirect | By Frazier Healthcare VI, L.P. |
Common Stock | Acquisiton | 2015-07-21 | 96,589 | $5.22 | 1,966,195 | No | 4 | J | Indirect | By Frazier Healthcare VI, L.P. |
Common Stock | Acquisiton | 2015-07-21 | 220,000 | $17.00 | 2,186,195 | No | 4 | P | Indirect | By Frazier Healthcare VI, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By Frazier Healthcare VI, L.P. |
No | 4 | J | Indirect | By Frazier Healthcare VI, L.P. |
No | 4 | P | Indirect | By Frazier Healthcare VI, L.P. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series D Preferred Stock | Disposition | 2015-07-21 | 1,869,606 | $0.00 | 1,869,606 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect |
Footnotes
- Each share of the issuer's Series D Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 21, 2015 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering pursuant to a registration statement on Form S-1 (File No. 333-204921) under the Securities Act of 1933, as amended, and had no expiration date.
- The reporting person, Alan Frazier, Nader Naini, Nathan Every and Patrick Heron are the managing members of FHM VI, LLC, which is the general partner of FHM VI, LP, which is the general partner of Frazier Healthcare VI, L.P. ("FHVI"), the record holder of the securities, and the reporting person may be deemed to share voting and dispositive power over the securities held by FHVI. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- Represents shares of Common Stock issued by the issuer in payment of cumulative accrued dividends.